Search Results - "Weisel KC"

Rhabdomyolysis and acute kidney injury.

Authors: Heyne N Guthoff M Weisel KC

Source: New England Journal of Medicine. 10/1/2009, Vol. 361 Issue 14, p1412-1413. 2p.

Effectiveness of linvoseltamab versus real-world standard-of-care in triple-class-exposed relapsed/refractory multiple myeloma in the United States.

Authors: Kumar S Weisel KC Spin P et al.

Source: Blood cancer journal [Blood Cancer J] 2026 Apr 01; Vol. 16 (1). Date of Electronic Publication: 2026 Apr 01.

Publication Type: Journal Article; Clinical Trial, Phase II; Clinical Trial, Phase I

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma.

Authors: Kumar S Jagannath S Weisel KC et al.

Source: Blood cancer journal [Blood Cancer J] 2026 Mar 25; Vol. 16 (1). Date of Electronic Publication: 2026 Mar 25.

Publication Type: Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II; Multicenter Study

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Erratum: Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.

Authors: Jin JX Ginde VR Huhn S et al.

Corporate Authors: Jin JX Ginde VR Huhn S et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2026 Jul 10; Vol. 44 (20), pp. 1955. Date of Electronic Publication: 2026 Jun 08.

Publication Type: Journal Article; Published Erratum

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE; In Process

Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.

Authors: Jin JX Ginde VR Huhn S et al.

Corporate Authors: Jin JX Ginde VR Huhn S et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2026 May 21, pp. JCO2502957. Date of Electronic Publication: 2026 May 21.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial.

Authors: Gay F Roeloffzen W Dimopoulos MA et al.

Source: Nature medicine [Nat Med] 2026 May; Vol. 32 (5), pp. 1773-1782. Date of Electronic Publication: 2026 Apr 06.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Prospective systematic classification of causes of death in the course of multiple myeloma.

Authors: Jin JX Besemer B Yilmaz B et al.

Source: Blood cancer journal [Blood Cancer J] 2025 Oct 20; Vol. 15 (1), pp. 167. Date of Electronic Publication: 2025 Oct 20.

Publication Type: Letter

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process

Current and future role of carfilzomib-based quadruplet combinations as therapy for newly diagnosed multiple myeloma.

Authors: Landgren O Biran N O'Donnell EK et al.

Source: HemaSphere [Hemasphere] 2025 Jul 16; Vol. 9 (7), pp. e70178. Date of Electronic Publication: 2025 Jul 16 (Print Publication: 2025).

Publication Type: Journal Article; Review

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

Isatuximab for the treatment of multiple myeloma: current clinical advances and future directions.

Authors: Richardson PG O'Donnell EK O'Gorman P et al.

Source: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2025 Jul-Aug; Vol. 34 (7-8), pp. 571-589. Date of Electronic Publication: 2025 Jul 23.

Publication Type: Journal Article; Review

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE

Comparative Effectiveness and Safety of PI-Rd Triplets in Relapsed/Refractory Multiple Myeloma: INSIGHT-MM Data Analysis.

Authors: Puig N Leleu X Lee HC et al.

Source: European journal of haematology [Eur J Haematol] 2026 Apr; Vol. 116 (4), pp. 458-470. Date of Electronic Publication: 2026 Jan 13.

Publication Type: Comparative Study; Journal Article; Multicenter Study; Observational Study

Journal Info: Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE

The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D.

Authors: Riedhammer C Truger M Lee H et al.

Source: Leukemia [Leukemia] 2026 Apr; Vol. 40 (4), pp. 730-738. Date of Electronic Publication: 2026 Feb 17.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

How to approach the high-risk myeloma from induction through relapse?

Authors: Weisel KC Schaefers C Leypoldt LB

Source: Hematology. American Society of Hematology. Education Program [Hematology Am Soc Hematol Educ Program] 2025 Dec 05; Vol. 2025 (1), pp. 652-658.

Publication Type: Journal Article; Review

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 100890099 Publication Model: Print Cited Medium: Internet ISSN: 1520-4383 (Electronic) Linking ISSN: 15204383 NLM ISO Abbreviation: Hematology Am Soc Hematol Educ Program Subsets: MEDLINE

Ranking the Importance of Prognostic Factors for Relapsed/Refractory Multiple Myeloma: International Physician Panel Consensus Following a Systematic Literature Review.

Authors: Kumar S Leleu X Weisel KC et al.

Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2025 Oct; Vol. 25 (10), pp. 730-738.e11. Date of Electronic Publication: 2025 Apr 03.

Publication Type: Journal Article; Systematic Review; Consensus Statement

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Practical Guidance on Clinical Management of Belantamab Mafodotin-Associated Ocular Events.

Authors: Terpos E Trudel S Mateos MV et al.

Source: American journal of hematology [Am J Hematol] 2025 Oct; Vol. 100 (10), pp. 1839-1850. Date of Electronic Publication: 2025 Jul 28.

Publication Type: Journal Article; Systematic Review; Practice Guideline; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

EHA-EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma.

Authors: Dimopoulos MA Terpos E Boccadoro M et al.

Source: Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2025 Sep; Vol. 22 (9), pp. 680-700. Date of Electronic Publication: 2025 Jul 07.

Publication Type: Journal Article; Review

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500077 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-4782 (Electronic) Linking ISSN: 17594774 NLM ISO Abbreviation: Nat Rev Clin Oncol Subsets: MEDLINE

Temporal genomic dynamics shape clinical trajectory in multiple myeloma.

Authors: Maura F Kaddoura M Poos AM et al.

Source: Nature genetics [Nat Genet] 2025 Sep; Vol. 57 (9), pp. 2203-2214. Date of Electronic Publication: 2025 Aug 20.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE

Cardiac biomarkers for risk stratification in newly diagnosed high-risk multiple myeloma in the GMMG-CONCEPT trial.

Authors: Leypoldt LB Guo L Besemer B et al.

Source: Cardio-oncology (London, England) [Cardiooncology] 2025 Jul 03; Vol. 11 (1), pp. 63. Date of Electronic Publication: 2025 Jul 03.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101689938 Publication Model: Electronic Cited Medium: Internet ISSN: 2057-3804 (Electronic) Linking ISSN: 20573804 NLM ISO Abbreviation: Cardiooncology Subsets: PubMed not MEDLINE

Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG ReLApsE trial.

Authors: Baertsch MA Schlenzka J Hielscher T et al.

Source: Blood [Blood] 2025 Apr 17; Vol. 145 (16), pp. 1780-1787.

Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial.

Authors: Mai EK Bertsch U Pozek E et al.

Corporate Authors: Mai EK Bertsch U Pozek E et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2025 Apr 10; Vol. 43 (11), pp. 1279-1288. Date of Electronic Publication: 2024 Dec 09.

Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients.

Authors: Thompson MA Boccadoro M Leleu X et al.

Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2023 Mar; Vol. 23 (3), pp. e171-e181. Date of Electronic Publication: 2022 Dec 07.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE